Laxxon Medical | WebDisclosure

Basculer en Français

10680	Companies
228005	Keywords
156514	Articles
120875	Press releases

Home
Companies
Laxxon Medical

PRESS RELEASE

published on 10/14/2024 at 16:00, 1 year 8 months ago

Laxxon Medical to Present Innovative Oral GLP-1 Agonist with Multi-Compartment Micro-Tablet Form, Aiming to Enhance Patient Compliance for Special Patient Groups, at the 2024 BIO Europe Convention
Laxxon Medical to showcase innovative oral GLP-1 Agonist micro-tablet at 2024 BIO Europe Convention, aiming to enhance patient compliance. Event aims to discover new partnerships

Laxxon Medical Oral GLP-1 Agonist Patient Compliance Micro-tablet BIO Europe Convention
BRIEF

published on 10/09/2024 at 20:06, 1 year 8 months ago

Laxxon Medical to Present SPID® Technology at CPHI Milan 2024

Laxxon Medical Pharmaceutical Manufacturing SPID® Technology CGMP Printing Technology CPHI Milan 2024
BRIEF

published on 10/09/2024 at 20:06, 1 year 8 months ago

Laxxon Medical présentera la technologie SPID® au CPHI Milan 2024

Laxxon Medical Fabrication Pharmaceutique Technologie SPID® CPHI Milan 2024 Technologie D'impression CGMP
PRESS RELEASE

published on 10/09/2024 at 20:01, 1 year 8 months ago

Laxxon Medical to Attend CPHI Milan 2024, Showcasing the cGMP Printing Technology at Adare Pharma Solution’s Facility in Pessano, Italy
Laxxon Medical to showcase cGMP Printing Technology at CPHI Milan 2024, unveiling innovative oral drug delivery systems through SPID® Technology

Laxxon Medical SPID® Technology CGMP Printing CPHI Milan Oral Drug Delivery
BRIEF

published on 10/01/2024 at 15:05, 1 year 9 months ago

Laxxon Medical et Adare Pharma Solutions annoncent une coopération conjointe pour la production de formes posologiques orales imprimées en 3D cGMP en Europe et aux États-Unis

Production CGMP Laxxon Medical Adare Pharma Partenariat Pharmaceutique Médicaments Imprimés En 3D
BRIEF

published on 10/01/2024 at 15:05, 1 year 9 months ago

Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US

CGMP Production Laxxon Medical Pharma Partnership 3D Printed Drugs Adare Pharma
PRESS RELEASE

published on 10/01/2024 at 15:00, 1 year 9 months ago

Laxxon Medical and Adare Pharma Solutions Announce Joint Cooperation for Production of cGMP 3D Printed Oral Dosage Forms in Europe and US
Laxxon Medical & Adare Pharma Cooperate for cGMP 3D Printed Oral Dosage Forms production in Europe & US. Utilizing SPID® Technology by Laxxon & Adare's cGMP-certified facilities

Drug Delivery Laxxon Medical 3D Printed Adare Pharma Solutions CGMP
BRIEF

published on 05/22/2024 at 15:10, 2 years 1 month ago

Laxxon Medical annonce le développement d'un actif GLP-1 oral non invasif

Laxxon Medical Traitement De L'obésité Agoniste Du Récepteur GLP-1 Technologie SPID® Voie 505(b)2
BRIEF

published on 05/22/2024 at 15:10, 2 years 1 month ago

Laxxon Medical Announces Development of Non-Invasive Oral GLP-1 Asset

Obesity Treatment Laxxon Medical GLP-1 Receptor Agonist SPID® Technology 505(b)2 Pathway
PRESS RELEASE

published on 05/22/2024 at 15:05, 2 years 1 month ago

Laxxon Medical Announces Development Program for Non-Invasive, 3D Printed Oral GLP-1 Asset, Offering an Alternative to GLP-1 Injections on Market
Laxxon Medical announces development program for LXM.2, a 3D printed oral GLP-1 receptor agonist for obesity treatment, offering an alternative to injections. Utilizes SPID® platform technology for enhanced bioavailability

Obesity Treatment Laxxon Medical GLP-1 LXM.2 3D Printed

Accesswire

Published on 07/03/2026 at 23:00, 19 hours 35 minutes ago

Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West
Published on 07/03/2026 at 23:00, 19 hours 35 minutes ago

Medicure Announces CFO Change
Published on 07/03/2026 at 21:28, 21 hours 7 minutes ago

Trifecta Gold Announces Closing of $1.66 Million Private Placement
Published on 07/03/2026 at 19:30, 23 hours 5 minutes ago

Polaris Renewable Energy Announces Q2 2026 Investor Call Details
Published on 07/03/2026 at 13:30, 1 day 5 hours ago

Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation

View all ACCESSWIRE

EQS Group

Published on 07/04/2026 at 17:35, 1 hour ago

Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247
Published on 07/04/2026 at 11:01, 7 hours 34 minutes ago

EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector
Published on 07/04/2026 at 09:05, 9 hours 30 minutes ago

Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love
Published on 07/03/2026 at 19:00, 23 hours 35 minutes ago

PATRIMOINE ET COMMERCE: BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE AU 30 JUIN 2026
Published on 07/03/2026 at 18:55, 23 hours 40 minutes ago

Saudia Arabia's Mabani Aljazeera Group invests in Tatu City's Jabali Towers development

Les Echos

Published on 07/03/2026 at 21:49, 20 hours 46 minutes ago

Safran annonce la fin des négociations concernant le projet d'acquisition d’Exail Technologies.
Published on 07/03/2026 at 21:49, 20 hours 46 minutes ago

Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.
Published on 07/03/2026 at 18:42, 23 hours 53 minutes ago

Total number of voting rights and shares making up the share capital at June 30, 2026
Published on 07/03/2026 at 18:42, 23 hours 53 minutes ago

Capital et droits de vote au 30 juin 2026
Published on 07/03/2026 at 18:36, 23 hours 59 minutes ago

Disclosure of transactions in own shares from July 1 to July 3, 2026

View all LES ECHOS COMFI WIRE